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One of the ways in which the impact of the SARS-CoV-2 epidemic on 
mortality in different countries is compared is to assess the change in 
life expectancy at birth between 2019 and 2020 (on the assumption 
that mortality rates in 2019 are a reasonable estimate of the non-
COVID-19 mortality rates for 2020). Although at this point there 
are no global estimates from bodies such as the Institute of Health 
Metrics and Evaluation and the United Nations Population Division, 
there are published estimates of the actual change in life expectancy 
between 2019 and 2020 for ~30 countries.[1,2]
While it is generally assumed that COVID-19 mortality rates 
increase exponentially with age[3] (although the rate of increase is not 
constant if there are significant comorbidities) and are greater for males 
than for females,[4,5] and hence that there will have been a significant 
drop in life expectancy between 2019 and 2020 as a result of the 
increase in mortality rates due to COVID-19, it is wrong to assume that 
the drop will always be substantial or that it will be greater for males 
than females when considering all causes of death combined.
Methods
The methods are described in more detail in the annual Rapid 
Mortality Surveillance (RMS) Report for 2020,[6] but essentially 
the numbers of registered deaths by age and sex recorded on the 
National Population Register (NPR) for each year from 2000 to 2020 
are increased to account for both registered deaths that were not 
captured by the NPR and an estimate of deaths that were not reported 
at all. These numbers, together with estimates of the numbers in the 
population in the middle of each of these years, are used to produce 
mortality rates and hence life tables that allow for the estimation of 
the various indicators.
The impact of the SARS-CoV-2 epidemic is described by reporting 
on the change in numbers of deaths, life expectancy and selected 
measures of mortality rates by age group between 2019 and 2020 for 
males and females, combined and separately.
Results
There were nearly 53 000 more deaths in 2020 than in 2019, of which 
65% were female. Although the greater proportion of deaths being 
female is generally due to the interaction of the increasing proportion 
of the population by age who are female and the exponentially 
higher mortality with increase in age, the difference is also due, 
more markedly, to the impact of interventions, particularly during 
strict lockdown, on non-COVID-19 mortality. As can be seen from 
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Background. The impacts on mortality of both the SARS-CoV-2 epidemic and the interventions to manage it differ between countries. The 
Rapid Mortality Surveillance System set up by the South African Medical Research Council based on data from the National Population 
Register (NPR) provides a means of tracking this impact on mortality in South Africa.
Objectives. To report on the change in key metrics of mortality (numbers of deaths, life expectancy at birth, life expectancy at age 60, and 
infant, under-5, older child and adolescent, young adult,  and adult mortality) over the period 2015 - 2020. The key features of the impact 
are contrasted with those measured in other countries.
Methods. The numbers of registered deaths by age and sex recorded on the NPR were increased to account for both registered deaths 
that are not captured by the NPR and an estimate of deaths not reported. The estimated numbers of deaths together with estimates of the 
numbers in the population in the middle of each of the years were used to produce life tables and calculate various indicators.
Results. Between 2019 and 2020, the number of deaths increased by nearly 53 000 (65% female), and life expectancy at birth fell by 1 year 
for females and by only 2.5 months for males. Life expectancy at age 60 decreased by 1.6 years for females and 1.2 years for males. Infant 
mortality, under-5 mortality and mortality of children aged 5 - 14 decreased by 22%, 20% and 10%, respectively, while that for older children 
and adolescents decreased by 11% for males and 5% for females. Premature adult mortality, the probability of a 15-year-old dying before age 
60, increased by 2% for males and 9% for females.
Conclusions. COVID-19 and the interventions to manage it had differential impacts on mortality by age and sex. The impact of the 
epidemic on life expectancy in 2020 differs from that in most other, mainly developed, countries, both in the limited decline and also in 
the greater impact on females. These empirical estimates of life expectancy and mortality rates are not reflected by estimates from agencies, 
either because agency estimates have yet to be updated for the impact of the epidemic or because they have not allowed for the impact 
correctly. Trends in weekly excess deaths suggest that the drop in life expectancy in 2021 will be greater than that in 2020.
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the impact on a number of indicators of the trends in mortality over 
recent years in Table 1, the epidemic led to a decline in life expectancy 
from 2019 to 2020 of only 0.6 years (1 year for females and 0.2 years 
for males).
The source of these somewhat surprising changes in life expectancy 
can be found in the other indicators. To some extent the change in 
adult mortality is as might have been expected, albeit somewhat more 
muted. For example, life expectancy at age 60 decreased from 2019 
to 2020 for both males and females by 1.3 and 1.6 years, respectively, 
while adult mortality (as measured by the probability of a 15-year-
old dying before reaching age 60, 45q15) increased for both sexes 
(although, again, less so for males than females, mainly owing to the 
greater impact for males of the decline in unnatural deaths).
While some of the effect of the reduction in non-COVID-19 
mortality due to interventions is apparent in the low increase in 
adult mortality, particularly for males, between 2019 and 2020, it 
is more apparent when considering infant, childhood, adolescent 
and young adult mortality. Although proportionately the same for 
males and females, infant and under-5 mortality dropped by ~21% 
(22% and 20%, respectively) between 2019 and 2020, and by ~10% 
for older children, adolescents and young adults. These changes 
are mainly due to a drop in non-COVID-19 communicable diseases 
in the infants and young children and in unnatural deaths in older 
adolescents and young adults.
Discussion
During 2020, the RMS System was modified to track the weekly 
number of deaths and thereby provide critical insight into the impact 
of COVID-19 in near to real time.[7,8]
The two key features of the impact of the SARS-CoV-2 epidemic 
on life expectancy in South Africa (SA) in 2020 are the seemingly 
modest impact relative to countries with similar levels of infection 
(particularly given the high level of comorbidities in SA[9]) and the 
fact that the impact on life expectancy of females was greater than 
that on life expectancy of males. For example, only seven countries 
(all with lower prevalences of SARS-CoV-2) out of 29 considered by 
Aburto et al.[1] experienced a lower change in life expectancy between 
2019 and 2020, and only three showed a lower drop in male than 
female life expectancy; all of these were smaller than that found in 
SA. And in the case of Brazil[2] the decline was 1.3 years, with the drop 
for males being higher than that for females (1.6 years v. 0.95 years).
The major reasons for this relatively unique outcome are the early, 
strict and to some extent long-lasting lockdown, and the fact that 
the mortality in 2019 overestimates the expected non-COVID-19 
mortality in 2020 in SA. Since the trend in the total number of 
deaths over time has been downward, mainly as a result of treatment 
of people with HIV, the mortality in 2020 without COVID-19 can 
be expected to be lower than that in 2019. Deaths due to all causes 
combined in 2020 in excess of what might have been expected 
without the epidemic are therefore estimated to be nearly 74 000, of 
which 71% were female.[10]
The only other estimate of change in life expectancy between 2019 
and 2020 for SA is that of Statistics South Africa,[11] which suggests 
a similar decline of 1.5 years and also a lesser impact for males than 
for females (1.4 years v. 1.6 years) for the calendar years. However, 
these estimates appear to reflect only the impact of their estimate of 
the total COVID-19 deaths (derived in an unclear way from the total 
number of excess deaths estimated by the South African Medical 
Research Council-University of Cape Town collaboration) for 2020, 
and ignore the impact of the epidemic and efforts to manage the 
epidemic on non-COVID-19 mortality.
However, the drop in life expectancy in 2021 can be expected to 
be somewhat greater than that in 2020 because of the devastating 
second and third waves of the COVID-19 pandemic associated 
with new variants of the virus, and the waning effectiveness of 
interventions to control the spread of the virus.
Table 1. Selected indicators of the trend in mortality and the impact of the SARS-CoV-2 epidemic on mortality, 2015 - 2020
2015 2016 2017 2018 2019 2020
Life expectancy at birth (years) (e0)
Persons 63.3 63.9 64.6 64.8 65.3 64.7
Males 60.1 60.9 61.6 61.8 62.4 62.2
Females 66.6 66.9 67.6 67.9 68.2 67.2
Life expectancy at age 60 (years) (e60)
Persons 17.6 17.7 17.8 17.9 18.0 16.5
Males 15.5 15.6 15.7 15.9 16.1 14.8
Females 19.3 19.3 19.5 19.6 19.6 18.0
Adult mortality, % (45q15)
Persons 34 33 32 31 29 31
Males 40 39 38 37 35 36
Females 28 27 26 25 24 26
U5MR, per 1 000 live births 39 36 33 35 36 28
IMR, per 1 000 live births 28 26 23 26 27 21
Older children and young adolescents mortality rate, per 1 000 (10q5)
Persons 7.0 6.5 6.0 6.2 5.9 5.3
Males 7.8 7.4 7.0 7.0 6.7 6.1
Females 6.2 5.6 5.1 5.3 5.0 4.5
Older adolescents and youth mortality rate, per 1 000 (10q15)
Persons 22.3 21.7 21.4 20.8 20.5 18.7
Males 26.3 25.8 26.0 25.2 25.5 22.7
Females 18.4 17.5 16.9 16.4 15.5 14.8
U5MR = under-5 mortality rate; IMR = infant mortality rate.
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Conclusions
The somewhat surprising results suggest that care should be exercised 
when anticipating the impact of the SARS-CoV-2 epidemic in a 
particular country based on the experience in other countries and, 
given the delay in the release of official cause-of-death data (the most 
recently released data are for 2018[12]), highlight the critical role that 
rapid processing of local data could play. Mortality is determined 
not only by the extent of the epidemic and the level of comorbidities 
in a country, but also by efforts made to intervene and manage the 
epidemic. In the case of SA, the very severe lockdown early in the 
epidemic, with a higher level of popular support and enforcement than 
the continued lockdown, based on less convincing reasoning, resulted 
in a near shut-down of the economy, the closure of schools, a sharp 
decline in unnatural mortality[7,13] and a reduction in non-COVID-19 
communicable mortality, particularly in infants and young children.
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